Assyro AI

Orange Book product · Generic (ANDA)

BUPROPION HYDROCHLORIDE

BUPROPION HYDROCHLORIDE

Generic (ANDA)ANDA 211020TE AB3RX GRAVITI PHARMS
View BUPROPION HYDROCHLORIDE familyOpen on FDA Orange Book

At a glance

Jan 28, 2019

Approved

Generic (ANDA)

Application

AB3

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 28, 2019

    7 yr 6 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

BUPROPION HYDROCHLORIDE

Strength

150MG

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

TE code

AB3

Application

ANDA 211020

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of BUPROPION HYDROCHLORIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo